Omega Healthcare Investors CEO Pickett To Retire
Omega Healthcare Investors' CEO C. Taylor Pickett announced his retirement, effective March 1, 2023, after transforming the company into a leading healthcare REIT. Daniel Booth, currently COO, will succeed Pickett, with Pickett transitioning to non-executive chairman of the board. The leadership change is intended to ensure a smooth transition and continued strategic guidance for the company.
25-year Omega CEO behind over 10,000% return plans exit
Omega Healthcare Investors, Inc. announced a planned leadership transition with CEO Taylor Pickett retiring on October 1, 2026, after 25 years, during which the company achieved over a 10,000% total shareholder return. Matthew Gourmand, current President, will succeed Mr. Pickett as CEO, and Neal Ballew will take over from Bob Stephenson as CFO, who is also retiring. The transitions are part of a carefully managed, multi-year succession plan by the Board.
Omega Healthcare (NYSE: OHI) details CEO and CFO retirements with internal successors
Omega Healthcare Investors (NYSE: OHI) announced a leadership transition plan, with CEO Taylor Pickett retiring on October 1, 2026, and CFO Bob Stephenson retiring on August 1, 2026. President Matthew Gourmand will succeed Pickett as CEO, and Chief Accounting Officer Neal Ballew will take over as CFO. The outgoing executives will remain in consulting roles, and the company highlighted Pickett's 25-year tenure during which shareholder return exceeded 10,000%.
Omega Healthcare Is Maintained at Sector Perform by Scotiabank
Scotiabank has maintained its "Sector Perform" rating for Omega Healthcare. This indicates a neutral outlook on the company's stock performance relative to the broader sector.
Omega Healthcare Investors stock hits all-time high at 49.17 USD By Investing.com
Omega Healthcare Investors Inc. (OHI) stock has reached an all-time high of $49.17, marking a significant 38.25% total return over the past year. The healthcare REIT boasts a market capitalization of $15.18 billion and offers a 5.5% dividend yield, having consistently paid dividends for 24 years. This performance is supported by strong market fundamentals and better-than-expected Q1 2026 revenues of $323 million, despite a slight miss on EPS.
UBS reiterates Buy on Omega Healthcare stock, cites growth prospects
UBS has reiterated its "Buy" rating on Omega Healthcare Investors (OHI), setting a price target of $54.00, citing sustained earnings growth potential. The firm expects this growth to be driven by external acquisitions and efficient internal portfolio management, as Omega Healthcare has been consistently acquiring significant assets. Despite the stock appearing overvalued relative to its fair value by InvestingPro analysis, the company boasts a strong track record of 24 consecutive years of dividend payments with a 5.5% yield.
Omega Healthcare Investors stock hits all-time high at 49.17 USD By Investing.com
Omega Healthcare Investors Inc. (OHI) stock has reached an all-time high of $49.17, marking a 38.25% total return over the past year. The healthcare REIT now boasts a market capitalization of $15.18 billion and offers a 5.5% dividend yield, having paid dividends for 24 consecutive years. This milestone follows a strong first quarter in 2026, where the company reported revenues of $323 million, significantly surpassing expectations, despite a slight miss on EPS.
Fideuram Intesa Sanpaolo Private Banking S.P.A. Takes Position in Omega Healthcare Investors, Inc. $OHI
Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new stake of 236,497 shares in Omega Healthcare Investors, Inc. (NYSE:OHI) during the fourth quarter, valued at approximately $10.49 million. The real estate investment trust (REIT) reported Q1 earnings of $0.47 per share, missing estimates, while revenue exceeded expectations at $322.96 million. Omega Healthcare Investors also announced a quarterly dividend of $0.67, translating to an annualized yield of about 5.5%.
Do Stronger Results and Reaffirmed Ratings Redefine Omega Healthcare Investors’ Risk Profile and Strategy (OHI)?
Omega Healthcare Investors (OHI) recently received reaffirmed "Buy" ratings from UBS and Citi, with BMO maintaining a "Hold," following stronger quarterly revenue and net profit. This analyst confidence combined with improved fundamentals suggests Omega's operations align with external expectations. While recent performance supports stable cash generation, the core risk of tenant credit, including the ongoing Genesis bankruptcy, remains a key consideration for the healthcare REIT.
Arbejdsmarkedets Tillaegspension Takes $22.80 Million Position in Omega Healthcare Investors, Inc. $OHI
Arbejdsmarkedets Tillaegspension has acquired a new stake worth $22.80 million in Omega Healthcare Investors, Inc. (NYSE:OHI), purchasing 514,124 shares. Despite missing Q1 earnings estimates, Omega Healthcare Investors reported strong revenue growth of 16.7% year-over-year and maintains a quarterly dividend of $0.67 per share, yielding approximately 5.7%. Analysts currently have a consensus "Hold" rating for the stock with an average target price of $48.83.
Omega Healthcare (OHI) Gets a Buy from UBS
UBS analyst Michael Goldsmith maintained a Buy rating on Omega Healthcare (OHI) with a $54.00 price target. This follows a similar Buy rating from Citi, although BMO Capital maintained a Hold rating. Omega Healthcare recently reported Q1 revenues of $322.96 million and a net profit of $151.05 million, showing growth compared to the previous year.
UBS Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Raises Target Price to $54
UBS has reiterated its Buy rating for Omega Healthcare Investors Inc (OHI.US) and increased its target price to $54. This revised target price suggests an upside of 62.77% from the stock's last closing price. This indicates a positive outlook from UBS on the company's future performance.
Omega Healthcare Portfolio Cleanup Aims To Support Dividend Stability
Omega Healthcare Investors (NYSE:OHI) is divesting CommuniCare's skilled nursing assets and reassessing its exposure to Maplewood and Genesis due to financial pressures. This portfolio cleanup is aimed at supporting dividend stability and bolstering overall portfolio health amidst ongoing operator stress in the sector. Investors should monitor the speed of asset transitions and sales, updates on Maplewood and Genesis, and the continued coverage of the quarterly dividend by earnings and funds available for distribution.
Omega Healthcare Investors, Inc. Common Stock (NY: OHI
This page provides a list of recent press releases and news headlines concerning Omega Healthcare Investors, Inc. (NYSE: OHI). The news spans from August 2022 to October 2024, covering quarterly earnings reports, dividend announcements, business updates, and analyses related to the company's stock performance.
Bokf Na Buys 64,539 Shares of Omega Healthcare Investors, Inc. $OHI
Bokf Na significantly increased its stake in Omega Healthcare Investors (NYSE:OHI) by 51.8% in the fourth quarter, purchasing 64,539 additional shares to hold a total of 189,095 shares valued at $8.384 million. This comes as Omega Healthcare reported quarterly EPS of $0.47, missing estimates, but saw revenue rise 16.7% to $322.96 million and declared a quarterly dividend of $0.67 with a 5.8% yield. Analyst ratings suggest a "Hold" consensus with an average price target of $48.67.
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $52
BMO Capital has reiterated its 'Hold' rating for Omega Healthcare Investors Inc (OHI.US) and increased its target price to $52. This indicates a neutral but slightly more optimistic outlook on the company's stock by the analyst firm.
Omega Healthcare Investors, Inc. $OHI Stake Boosted by Strs Ohio
Strs Ohio increased its stake in Omega Healthcare Investors (OHI) by 21% in the fourth quarter, now owning 383,055 shares valued at approximately $16.99 million. Institutional investors collectively hold about 65.25% of the company's stock. Omega Healthcare Investors recently declared a quarterly dividend of $0.67 per share, yielding about 5.7%, and reported Q4 EPS of $0.47, missing estimates but with revenue beating forecasts and growing 16.7% year-over-year.
Horizon Investments LLC Reduces Stock Position in Omega Healthcare Investors, Inc. $OHI
Horizon Investments LLC decreased its stake in Omega Healthcare Investors (NYSE:OHI) by 19.3% in the fourth quarter of last year, selling 29,658 shares and leaving them with 123,846 shares valued at approximately $5.49 million. Omega Healthcare Investors has a consensus "Hold" rating from analysts with an average target price of $48.00, despite some varying opinions among firms. The company announced a quarterly dividend of $0.67 per share, yielding about 5.7%, and reported Q1 EPS of $0.47, missing estimates, but revenue of $322.96 million, which beat expectations.
Omega Healthcare Investors (OHI) Q1 FFO Highlights Tenant Risk Narrative Tension
Omega Healthcare Investors (OHI) reported Q1 2026 revenue of US$323 million and FFO per share of US$0.84, with trailing net margins improving to 49.7%. While current cash generation supports distributions, the article highlights tension between strong profitability and potential risks like tenant credit risk, straight-line rent accounting, and modest future revenue declines, inviting investors to weigh the bull versus bear case.
Citi Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Raises Target Price to $52
Citi has reiterated its Buy rating on Omega Healthcare Investors Inc (OHI.US) and increased the target price to $52. This positive revision by Citi indicates continued confidence in the company's performance and future outlook. The updated target price suggests potential upside for investors.
Omega Healthcare Investors (NYSE:OHI) Stock Price Expected to Rise, Citigroup Analyst Says
Citigroup has increased its price target for Omega Healthcare Investors (NYSE:OHI) from $50 to $52, maintaining a "buy" rating and suggesting a 10.61% upside from the current share price. This adjustment follows quarterly results where the company missed EPS but exceeded revenue expectations, with Q1 revenue up 16.7% year-over-year. Despite mixed analyst coverage, with an average "Hold" rating, several other firms have also recently updated their price targets for OHI.
Vanguard (OHI) discloses 15.69M shares, 5.30% stake disclosed in 13G
Vanguard Capital Management has disclosed a 5.30% stake in Omega Healthcare Investors Inc. (OHI), signaling a significant passive investment. The filing indicates Vanguard directly controls the disposition of 15,689,615 shares, while holding sole voting power over a smaller portion of 2,455,494 shares. This strategic disclosure, made via Schedule 13G, outlines the diverse control lines within Vanguard's affiliated entities.
Should Omega Healthcare Investors’ Strong Q1 2026 Results and Portfolio Moves Require Action From OHI Investors?
Omega Healthcare Investors reported robust Q1 2026 results, with increased revenue, net income, and a maintained dividend, alongside significant new investments and planned asset sales for portfolio repositioning. The company's investment narrative centers on addressing the long-term need for skilled nursing and senior care, supported by strong financial performance and strategic capital allocation. Investors are encouraged to consider the active investment pipeline and raised full-year AFFO guidance, while remaining aware of ongoing risks related to tenant credit and reimbursement policies.
Omega Healthcare Investors, Inc. (NYSE:OHI) Q1 2026 Earnings Call Transcript
Omega Healthcare Investors, Inc. (NYSE:OHI) reported strong Q1 2026 financial results, with adjusted FFO of $0.82 per share and FAD of $0.78 per share, driven by acquisitions and active portfolio management. The company also announced the strategic sale of 18 Communicare assets for $480 million, aiming for $0.03 annual AFFO and FAD accretion from redeploying these proceeds. Furthermore, Omega provided an update on its investment pipeline across skilled nursing, senior housing RIDEA, and UK care homes, emphasizing a focus on sustainable FAD per share growth.
Omega Healthcare Investors leverages RIDEA, regional operators for growth in competitive senior living market
Omega Healthcare Investors is increasingly using its RIDEA platform and partnering with experienced regional operators to pursue growth in the competitive senior living market. The REIT seeks off-market deals through relationships and prefers to trust the expertise of these operators rather than trying to dictate operations. Omega's investment pipeline is robust, with a significant focus on US senior housing assets, and the company remains agnostic to deal structure, prioritizing value creation.
Should Omega Healthcare Investors’ Strong Q1 2026 Results and Portfolio Moves Require Action From OHI Investors?
Omega Healthcare Investors reported robust Q1 2026 results, with increased revenue and net income, alongside new investments and a significant asset sale. These developments align with the company's strategy of growing income-producing assets and refining its portfolio focus. Investors should consider these strong results and strategic moves in light of ongoing risks related to tenant credit and reimbursement policies in the skilled nursing and senior care sectors.
Vanguard boosts passive stake in Omega Healthcare Investors (NYSE: OHI) to 9.18%
Vanguard Portfolio Management has disclosed a passive stake of 9.18% in Omega Healthcare Investors (OHI), representing 27,160,324 shares of common stock. This Schedule 13G filing indicates Vanguard has sole dispositive power over all these shares but sole voting power over only 37,207 shares. The filing, signed on April 29, 2026, attributes these holdings to various Vanguard funds and managed accounts.
Omega Healthcare Investors reports $322.955M revenue and $0.47 EPS in 10-Q
Omega Healthcare Investors reported total revenues of $322.955 million, an increase driven by higher rental and interest income, and achieved a diluted earnings per share of $0.47. The company's net income was $158.576 million. These results reflect continued portfolio expansion through acquisitions and new loan originations, alongside ongoing monitoring of the regulatory environment affecting operator performance.
Omega Healthcare (OHI) Q1 2026 Earnings Transcript
Omega Healthcare Investors (OHI) reported strong Q1 2026 results with adjusted FFO of $0.82 per share and FAD of $0.78 per share, driven by new investments and active portfolio management. The company invested $326 million year-to-date and strategically sold 18 CommuniCare facilities for $480 million, expecting $0.03 annual AFFO and FAD accretion from reinvestment. OHI also updated its full-year AFFO guidance to $3.19-$3.25 per share, reflecting ongoing capital allocation and portfolio adjustments.
US681936BP48 Latest News and Headlines
This page from TradingView provides a landing for news and headlines related to the corporate bond US681936BP48 issued by Omega Healthcare Investors, Inc. The main content indicates the bond is a 5.2% bond due July 1, 2030, traded on the Stuttgart Stock Exchange. The page largely consists of navigation and links to other TradingView services, with no actual news articles displayed.
Omega Healthcare Investors (OHI) Q1 FFO and Revenues Beat Estimates
Omega Healthcare Investors (OHI) reported Q1 funds from operations (FFO) of $0.82 per share and revenues of $322.96 million, both exceeding Zacks Consensus Estimates. While the company has consistently surpassed FFO estimates, its current Zacks Rank of #4 (Sell) suggests potential underperformance in the near future despite strong recent stock performance.
Omega Healthcare Investors (NYSE:OHI) Issues FY 2026 Earnings Guidance
Omega Healthcare Investors (NYSE:OHI) has issued its FY 2026 earnings guidance, projecting an EPS of $3.190-$3.250, which surpasses the consensus estimate of $3.070. Following this announcement, the stock traded up by 1.7% to $47.46. The company also declared a quarterly dividend of $0.67, translating to an annualized dividend of $2.68 and a 5.6% yield, despite missing Q1 EPS estimates while exceeding revenue expectations.
Omega Healthcare Investors: Q1 Earnings Snapshot
Omega Healthcare Investors Inc. (OHI) reported funds from operations of $260 million, or 82 cents per share, in its first quarter. The health care real estate investment trust posted net income of $151 million, or 47 cents per share, on revenue of $323 million. The company anticipates full-year funds from operations to be in the range of $3.19 to $3.25 per share.
Omega Healthcare (NYSE: OHI) lifts 2026 AFFO outlook after strong Q1
Omega Healthcare Investors (OHI) reported strong first-quarter 2026 results, with total revenues of $322.9 million and net income of $151.0 million, leading to an increase in FAD per share by 9.5%. Following this performance, the company raised its 2026 Adjusted FFO guidance midpoint to $3.22 per diluted share. Omega also engaged in significant investment and asset sale activities, completing $250.8 million in new investments in Q1 and an additional $75.0 million in Q2, alongside $34.5 million in asset sales and a planned $479.9 million skilled nursing portfolio disposition.
Earnings Flash (OHI) Omega Healthcare Investors, Inc. Reports Q1 Revenue $323.0M, vs. FactSet Est of $264.1M
Omega Healthcare Investors, Inc. announced its Q1 revenue reached $323.0 million, significantly surpassing FactSet's estimate of $264.1 million. The company also reported an increase in Q1 AFFO and revenue, leading to a raised 2026 guidance. This positive financial performance indicates strong growth for the specialized REIT.
Omega Healthcare Investors (NYSE:OHI) - Stock Analysis
This report provides a comprehensive stock analysis of Omega Healthcare Investors (NYSE:OHI), highlighting its strong dividend yield, fair valuation compared to peers, and stable share price. The company, a Real Estate Investment Trust focused on long-term healthcare facilities, is currently undervalued by analysts. Key takeaways emphasize demographic trends driving demand and prudent balance sheet management supporting revenue growth.
Omega Healthcare Investors, Inc. to Issue Quarterly Dividend of $0.67 (NYSE:OHI)
Omega Healthcare Investors, Inc. (NYSE:OHI) has declared a quarterly dividend of $0.67 per share, set to be paid on May 15th to shareholders of record on May 4th, representing an annualized yield of 5.8%. While the current payout ratio of 148.1% indicates difficulty in covering dividends solely from earnings, analysts project earnings next year will reduce this to 83.8%. The company specializes in acquiring and leasing long-term care properties, aiming for stable, inflation-protected cash flows.
Cornerstone Enterprises LLC Grows Stock Position in Omega Healthcare Investors, Inc. $OHI
Cornerstone Enterprises LLC increased its stake in Omega Healthcare Investors (NYSE:OHI) by 26.6% in the fourth quarter of 2025, now holding 246,589 shares valued at $10.93 million. Omega Healthcare Investors recently announced a quarterly dividend of $0.67, representing an annualized yield of 5.8%. Analysts have a consensus "Hold" rating for OHI, with an average price target of $47.83, while the stock currently trades around $46.36.
Omega Healthcare Investors, Inc expected to post earnings of 48 cents a share - Earnings Preview
Omega Healthcare Investors, Inc (OHI) is projected to report earnings of 48 cents per share. This financial forecast is provided by Refinitiv and is part of an earnings preview. The article details the expected earnings per share for the company.
Omega Healthcare Investors declares $0.67 dividend
Omega Healthcare Investors (OHI) announced a quarterly dividend of $0.67 per share, payable on May 15, 2026, to shareholders of record as of April 30, 2026. This translates to an annualized payout of $2.68 per share and represents a forward yield of 9.38% based on the current stock price.
Omega Announces Quarterly Dividend
Omega Healthcare Investors, Inc. (NYSE:OHI) announced a cash dividend of $0.67 per share on its common stock, payable on May 15, 2026, to stockholders of record as of May 4, 2026. The company is a real estate investment trust focused on the long-term healthcare industry, particularly skilled nursing and assisted living facilities, operating under a triple-net lease structure across the US, UK, and Canada.
Omega Announces Quarterly Dividend
Omega Healthcare Investors, Inc. (NYSE:OHI) announced a cash dividend of $0.67 per share on its common stock. The dividend is payable on May 15, 2026, to shareholders of record as of May 4, 2026. Omega primarily invests in skilled nursing and assisted living facilities across the US, UK, and Canada.
Zurcher Kantonalbank Zurich Cantonalbank Boosts Position in Omega Healthcare Investors, Inc. $OHI
Zurcher Kantonalbank Zurich Cantonalbank significantly increased its stake in Omega Healthcare Investors, Inc. (OHI) by 76.2% in Q4, now holding 321,275 shares valued at approximately $14.25 million. This institutional activity comes as several analysts have issued "Hold" ratings with an average price target of $47.83, though some have raised their targets. Omega Healthcare Investors recently paid a quarterly dividend of $0.67, representing a 6.0% yield, but its high payout ratio of 138.86% raises questions about dividend sustainability.
Precision Trading with Omega Healthcare Investors Inc. (OHI) Risk Zones
This article provides a detailed analysis of Omega Healthcare Investors Inc. (OHI) using AI models to identify risk zones and trading strategies. It highlights a weak near-term sentiment but an exceptional risk-reward setup targeting a 6.0% gain. The analysis includes position, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis for various holding periods.
CPC Advisors LLC Takes $3.05 Million Position in Omega Healthcare Investors, Inc. $OHI
CPC Advisors LLC has acquired a new stake of 68,790 shares, valued at approximately $3.05 million, in Omega Healthcare Investors (NYSE:OHI) during the fourth quarter. Institutional investors now hold about 65.25% of the company's stock. Analysts generally rate OHI as a "Hold" with an average target price of $47.83, though the company's high dividend payout ratio of 138.86% raises questions about dividend sustainability.
SageGuard Financial Group LLC Invests $1.68 Million in Omega Healthcare Investors, Inc. $OHI
SageGuard Financial Group LLC recently invested $1.68 million in Omega Healthcare Investors (NYSE:OHI), acquiring 37,985 shares in Q4. This move is part of broader institutional interest, with other hedge funds also increasing their stakes in the real estate investment trust. Despite a high dividend payout ratio, the stock maintains a consensus "Hold" rating from analysts, with various target price adjustments.
OMEGA HEALTHCARE INVESTORS INC ($OHI) CEO 2025 Pay Revealed
OMEGA HEALTHCARE INVESTORS INC ($OHI) CEO C. Taylor Pickett's estimated compensation for 2025 is $14,020,475, a 3.35% increase from 2024. This information comes from a recent SEC filing. The article also details recent insider trading activity, significant movements by hedge funds, and current analyst ratings and price targets for OHI stock.
OMEGA HEALTHCARE INVESTORS INC ($OHI) CEO 2025 Pay Revealed
OMEGA HEALTHCARE INVESTORS INC's CEO, C. Taylor Pickett, is estimated to have received $14,020,475 in compensation in 2025, a 3.35% increase from 2024, based on a recent SEC filing. The article also details recent insider trading activity for OHI, showing purchases by the CEO and CIO, as well as institutional investor movements and analyst ratings with a median price target of $48.0.
[ARS] OMEGA HEALTHCARE INVESTORS INC SEC Filing
This article announces an SEC filing (Form ARS) by Omega Healthcare Investors Inc. (OHI) on April 21, 2026, at 09:01 AM. The filing is available as a PDF document and has a low impact and neutral sentiment. The article also provides a brief overview of OHI's stock data, rankings, and recent news and SEC filings.
Assessing Omega Healthcare Investors (OHI) Valuation After Strong Multi Year Shareholder Returns
Omega Healthcare Investors (OHI) has shown strong share performance with a 3-year total shareholder return of 121.17%. The company is currently trading at $46.51, slightly below its narrative fair value of $49.63, indicating it may be undervalued. Its valuation is supported by disciplined balance sheet management and strategic acquisitions, but potential risks include tenant credit issues and regulatory changes.
